Thomas Gerstberger

3.4k total citations
12 papers, 411 citations indexed

About

Thomas Gerstberger is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Thomas Gerstberger has authored 12 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Hematology and 1 paper in Organic Chemistry. Recurrent topics in Thomas Gerstberger's work include Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). Thomas Gerstberger is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). Thomas Gerstberger collaborates with scholars based in Austria, Germany and United States. Thomas Gerstberger's co-authors include Ed Hurt, Vikram Govind Panse, Bernhard Küster, Markus Künzler, F. Ralf Bischoff, Françoise Stutz, Laetitia J. Martin, Jessica L. Minder, Yutaka Suzuki and Mark Pearson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Cell Biology.

In The Last Decade

Thomas Gerstberger

11 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Gerstberger Austria	6	395	73	65	32	28	12	411
Catherine Berset Switzerland	8	339 0.9×	37 0.5×	74 1.1×	49 1.5×	10 0.4×	12	416
Pavel Němec Czechia	9	158 0.4×	103 1.4×	51 0.8×	58 1.8×	19 0.7×	38	319
Gregg Wallis United Kingdom	8	175 0.4×	77 1.1×	26 0.4×	18 0.6×	11 0.4×	14	285
Markus Dangl Germany	10	256 0.6×	47 0.6×	91 1.4×	16 0.5×	10 0.4×	14	339
Haipeng Guan China	5	424 1.1×	17 0.2×	51 0.8×	13 0.4×	8 0.3×	7	460
René Martin Linka Germany	8	126 0.3×	44 0.6×	83 1.3×	15 0.5×	20 0.7×	9	285
Ka Yim Chan-Salis United States	4	293 0.7×	16 0.2×	75 1.2×	37 1.2×	4 0.1×	4	340
Jijun Yuan China	11	240 0.6×	24 0.3×	67 1.0×	11 0.3×	23 0.8×	22	354
Adrian E. Rice United States	8	273 0.7×	75 1.0×	28 0.4×	30 0.9×	4 0.1×	8	425
Mariano Oppikofer Switzerland	11	552 1.4×	37 0.5×	44 0.7×	16 0.5×	11 0.4×	13	593

Countries citing papers authored by Thomas Gerstberger

Since Specialization

Citations

This map shows the geographic impact of Thomas Gerstberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gerstberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gerstberger more than expected).

Fields of papers citing papers by Thomas Gerstberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gerstberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gerstberger. The network helps show where Thomas Gerstberger may publish in the future.

Co-authorship network of co-authors of Thomas Gerstberger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gerstberger. A scholar is included among the top collaborators of Thomas Gerstberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gerstberger. Thomas Gerstberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Scott, Thomas Allan, Christian A. Smethurst, Moriz Mayer, et al.. (2025). Drugit: crowd-sourcing molecular design of non-peptidic VHL binders. Nature Communications. 16(1). 3548–3548.

Gerstberger, Thomas, Helmut Berger, Frank Büttner, et al.. (2024). Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical Assays. Journal of Medicinal Chemistry. 67(14). 11701–11711. 4 indexed citations

Martinelli, Paola, Otmar Schaaf, Andreas Mantoulidis, et al.. (2023). Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and in vivo Experiments. ChemMedChem. 18(6). e202200686–e202200686. 3 indexed citations

Neumüller, Ralph A., Birgit Wilding, Dirk Scharn, et al.. (2021). Abstract 1472: Novel EGFR WT sparing, HER2 selective inhibitors for the treatment of HER2 exon 20 insertion driven tumors address a clear unmet medical need. Cancer Research. 81(13_Supplement). 1472–1472. 1 indexed citations

Gerlach, Daniel, Ulrike Tontsch-Grunt, Anke Baum, et al.. (2018). The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML. Oncogene. 37(20). 2687–2701. 66 indexed citations

Hohmann, Anja, Laetitia J. Martin, Jessica L. Minder, et al.. (2016). Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition. Nature Chemical Biology. 12(9). 672–679. 134 indexed citations

Hohmann, Anja, Laetitia J. Martin, Jessica L. Minder, et al.. (2016). Abstract LB-206: A bromodomain-swap allele demonstrates that on-target chemical inhibition of BRD9 limits the proliferation of acute myeloid leukemia cells. Cancer Research. 76(14_Supplement). LB–206. 3 indexed citations

Tontsch-Grunt, Ulrike, Fabio Savarese, Daniel Gerlach, et al.. (2015). Abstract B79: BI 894999, a novel BET inhibitor: Treatment of hematological malignancies by repression of super-enhancer driven oncogenes. Molecular Cancer Therapeutics. 14(12_Supplement_2). B79–B79. 4 indexed citations

Fromont‐Racine, Micheline, Pierre Legrain, F. Ralf Bischoff, et al.. (2003). Identification and Characterization of a Novel RanGTP-binding Protein in the Yeast Saccharomyces cerevisiae. Journal of Biological Chemistry. 278(17). 15397–15405. 8 indexed citations

10.

Panse, Vikram Govind, Bernhard Küster, Thomas Gerstberger, & Ed Hurt. (2002). Unconventional tethering of Ulp1 to the transport channel of the nuclear pore complex by karyopherins. Nature Cell Biology. 5(1). 21–27. 107 indexed citations

11.

Künzler, Markus, Thomas Gerstberger, Françoise Stutz, F. Ralf Bischoff, & Ed Hurt. (2000). Yeast Ran-Binding Protein 1 (Yrb1) Shuttles between the Nucleus and Cytoplasm and Is Exported from the Nucleus via a CRM1 ( XPO1 )-Dependent Pathway. Molecular and Cellular Biology. 20(12). 4295–4308. 49 indexed citations

12.

Krappmann, Sven, Kerstin Helmstaedt, Thomas Gerstberger, et al.. (1999). The aroC Gene of Aspergillus nidulansCodes for a Monofunctional, Allosterically Regulated Chorismate Mutase. Journal of Biological Chemistry. 274(32). 22275–22282. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact